Shop Architect™, Abbott, R1: 43.9 mL, R2: 43.9 mL
- Application
- Test Category
- Levels
-
For Use With
- For use in Evaluating and Monitoring of Qualitative Molecular Diagnostic Assays for Detection of Norovirus GI / GII Nucleic Acid (1)
- For Nucleic Acid Tests (10)
- For Clinical Specimen (7)
- For Quality Control of Clinical Assays and Training of Laboratory Personnel (6)
- For Clinical Assays, Development of Diagnostic Tests and Training of Laboratory Personnel, Qualitative Molecular Assays (4)
- For Evaluating Performance of Nucleic Acid Tests for Determination of the Presence of C. Trachomatis, N. Gonorrhoeae and T. Vaginalis DNA (4)
- For Evaluating the Performance of Nucleic Acid Tests for Determination of the Presence of SARS-CoV-2 RNA (4)
- For Qualitative Molecular Assays (4)
- For Determination of Presence of S. Aureus DNA, Validation of Clinical Assays, Development of Diagnostic Tests and Training of Laboratory Personnel (3)
- For Evaluating Performance of Molecular Tests (3)
- For Evaluating Test Performance of Molecular Assays which detect Mpox Virus Nucleic Acids (3)
- For Quality Control of Clinical Assays and Training of Laboratory Personnel, Clinical Specimen (3)
- For Quality Control of Clinical Assays and Training of Laboratory Personnel, Qualitative Molecular Assays (3)
- For Verification of Clinical Assays, Development of Diagnostic Tests and Training of Laboratory Personnel (3)
- For Determination of Presence of Group B Streptococci (GBS) DNA, Validation of Clinical Assays, Development of Diagnostic Tests and Training of Laboratory Personnel (2)
- For Determination of Presence of Viral and Bacterial Nucleic Acids, Verification of Clinical Assays, Development of Diagnostic Tests and Training of Laboratory Personnel (2)
- For Determination of the Presence of BV DNA Markers (2)
- For Evaluating Performance of Nucleic Acid Tests For Determination of The Presence of Bacterial Nucleic Acids (2)
- For Evaluating Test Performance of Atopobium Vaginae, BVAB2, Candida Albicans, Candida Glabrata, and Trichomonas Vaginalis Molecular Assays (2)
- For Evaluating the Performance of Molecular Tests (2)
- For Evaluating the Performance of Nucleic Acid Tests (2)
- For Evaluating the Performance of Nucleic Acid Tests for Determination of the Presence of Viral and Bacterial Nucleic Acid (2)
- For Evaluation of the Performance of Nucleic Acid Tests for Determination of the Presence of SARS-CoV-2 RNA (2)
- For use with Real-Time PCR Thermal Cycler (2)
- For BD MAX™ Vaginal Panel Assay (1)
- For Clinical Assays, Development of Diagnostic Tests and Training of Laboratory Personnel (1)
- For Determination of Presence of Bacterial DNA (1)
- For Determination of Presence of C. Difficile DNA, Validation of Clinical Assays, Development of Diagnostic Tests and Training of Laboratory Personnel (1)
- For Determination of Presence of C. Trachomatis DNA, Validation of Clinical Assays, Development of Diagnostic Tests and Training of Laboratory Personnel (1)
- For Determination of Presence of N. Gonorrhoeae DNA, Validation of Clinical Assays, Development of Diagnostic Tests and Training of Laboratory Personnel (1)
- For Determination of the Presence of Respiratory Virus Nucleic Acids (1)
- For Evaluating Nucleic Acid Tests For S. Aureus DNA (1)
- For Evaluating Performace of Molecular Tests (1)
- For Evaluating Performance of Molecular Assays (1)
- For Evaluating Performance of Nucleic Acid Tests for Determination of Presence of Bacterial Nucleic Acids (1)
- For Evaluating Performance of Nucleic Acid Tests for Determination of Presence of Norovirus Nucleic Acid (1)
- For Evaluating Performance of Nucleic Acid Tests for Determination of the Presence of Bacterial, Fungal, and Viral Nucleic Acids (1)
- For Evaluating Performance of Nucleic Acid Tests for Determination of the Presence of HSV 1 and 2 Nucleic Acids (1)
- For Evaluating and Monitoring of Qualitative Molecular Diagnostic Assays for the Detection of the absence of Norovirus Nucleic Acid (1)
- For Evaluating the Performance of Nucleic Acid Tests for Determination of the Prescence of SARS-CoV-2 RNA (1)
- For Evaluating the Performance of Nucleic Acid Tests for Determination of the Presence of Bacterial Nucleic Acids (1)
- For Evaluating the Performance of Nucleic Acid Tests for Determination of the Presence of Bacterial and Fungal Nucleic Acids (1)
- For Evaluating the Performance of Nucleic Acid Tests for Determination of the Presence of Respiratory Virus Nucleic Acids (1)
- For Evaluating the Performance of Nucleic Acid Tests for Determination of the Presence of T. Vaginalis Nucleic Acid (1)
- For Evaluating the Performance of Nucleic Acid Tests for Determination of the Presence of T. vaginalis Nucleic Acids (1)
- For Evaluating the Performance of Nucleic Acid Tests for Determination of the Presence of Viral and Bacterial Nucleic Acids (1)
- For Evaluating the Performance of Nucleic Acid Tests for determination of the presence of Bacterial, Parasitic and Viral Nucleic Acids (1)
- For Evaluation of the Performance of Molecular Tests (1)
- For Evaluation of the Performance of Nucleic Acid Tests for Determination of the Presence of Bacterial Nucleic Acids (1)
- For Gastrointestinal Panel Nucleic Acid Test (1)
- For Molecular Assays that Detect Nucleic Acids from the Organisms (1)
- For Verification of Performance of Molecular Assays that Detect the Presence of Bacterial and Viral Nucleic Acids (1)
- For use with BioFire FilmArray System (1)
- For use with Qualitative Molecular Assays (1)
- Country of Origin
- Trade Agreement Act (TAA) Compliant
- Buy American Act (BAA) Compliant
(0)
-
- Select Items to see more options
- Compare Items
- Compare
-
,for, Item ID-
- #1155474
- ZeptoMetrix Corp #NATNOV-6MC-IVD
Log in for pricing and availability